India, Nov. 30 -- Much like other sectors, AI has become indispensable in the life sciences sector, accelerating progress in healthcare, pharmaceuticals, genomics, and biotechnology. To put things in perspective, the global AI market in the pharmaceutical industry is projected to reach $16.49 billion by 2034, while AI in the medical devices segment is expected to scale up to $97.1 billion by 2028, fuelled by the widespread use of AI-powered diagnostic systems, smart wearables, and surgical robotics.

Across this fast-changing landscape, AI professionals are becoming the most sought-after by organisations in the life sciences segment. These experts are redefining how diseases are diagnosed, drugs are discovered, and care is delivered. For ...